Marc Rivière
Bioinformatics & Systems Biology
Cerenis Therapeutics
France
Biography
Dr. Marc Rivière has been a General Partner at the Montreal-based TVM Capital Life Science team since 2013. Previously he was Vice-President, Axcan Pharma Inc., in charge of Clinical Development and Medical Affairs. Marc’s expertise encompasses various clinical areas from pre-clinical development to post-marketing surveillance. He is a director of GLWL Inc. and an observer on the Board of Colucid Inc.
Research Interest
Bioinformatics & Systems Biology, biochemistry, immunology, molecular biology
